Skip to main content
. Author manuscript; available in PMC: 2022 Dec 23.
Published in final edited form as: Lancet Neurol. 2022 Apr 25;21(6):563–576. doi: 10.1016/S1474-4422(22)00035-7

Figure 2: Location of recurrent* variants on the CDKL5 protein.

Figure 2:

The inset shows an expanded diagram of the catalytic domain. NLS1=nuclear localisation signal 1. NLS2=nuclear localisation signal 2. *Variants affecting three or more individuals.